Nestlé’s, Twin-Track

Nestlé’s Twin-Track Strategy: Portfolio Surgery Meets a Surprise Sales Beat

28.04.2026 - 23:41:13 | boerse-global.de

Nestlé sells Blue Bottle Coffee, seeks $5B water JV partner, and plans 16,000 job cuts as it narrows focus to four core categories amid better-than-expected growth.

Nestlé’s Twin-Track Strategy: Portfolio Surgery Meets a Surprise Sales Beat - Foto: über boerse-global.de
Nestlé’s Twin-Track Strategy: Portfolio Surgery Meets a Surprise Sales Beat - Foto: über boerse-global.de

Nestlé is simultaneously executing a dramatic portfolio overhaul and delivering quarterly numbers that have caught the market off guard. The Swiss food giant’s latest moves — from selling off a prized coffee chain to seeking a joint venture partner for its water division — are unfolding against a backdrop of better-than-expected organic growth, creating a narrative that is as much about transformation as it is about resilience.

A Coffee Divestiture That Tells a Story

The most immediate transaction is the sale of Blue Bottle Coffee to Chinese private equity firm Centurium Capital. Nestlé acquired a majority stake in the premium coffee chain back in 2017 for an estimated $425 million, but the exit price remains undisclosed. Reports suggest it falls short of that original figure. The deal is expected to close in the first half of 2026.

What makes this sale particularly telling is what Nestlé keeps: the rights to Blue Bottle-branded Nespresso-compatible capsules. Chief executive Philipp Navratil is doubling down on scalable global platforms like Nespresso and Nescafé, while shedding the capital-intensive, operationally demanding retail business. The message is clear — the group wants brand equity without the overhead.

Waters: The Bigger Prize

The Blue Bottle disposal, however, is a sideshow compared to what is happening in the waters division. Nestlé is actively pursuing a 50% stake sale in its global water business, with private equity heavyweights Blackstone, Bain, KKR and PAI all circling. The deal is valued at around $5 billion, and the company expects to deconsolidate the unit from 2027 onwards.

Should investors sell immediately? Or is it worth buying Nestle?

This is a division with baggage. In March 2024, Nestlé faced allegations over production methods at its Perrier and Vittel brands, including claims that illegal treatment processes were used and that tap water was marketed as mineral water. While the company insists its motivation is purely strategic simplification, the reputational damage cannot have helped the urgency.

Alongside the waters sale, Nestlé is also offloading its mainstream vitamins business, which includes brands like Nature’s Bounty and Puritan’s Pride. And in a quieter but symbolic move, the founders of German spice brand Ankerkraut — Anne and Stefan Lemcke — have bought back the roughly 85% stake Nestlé held. The integration had clearly struggled: employee numbers fell from over 230 to around 160 under Nestlé’s ownership.

The Cost of Simplification

This sweeping portfolio rationalisation comes at a price. Nestlé plans to cut around 16,000 jobs by the end of 2027, targeting cost savings of 3 billion Swiss francs. The group is narrowing its focus to just four core categories, and everything that does not fit is being jettisoned.

Yet the share price tells a more nuanced story. At around 80 CHF, the stock sits roughly 6% above its 52-week low from 21 April, but remains nearly 5% below its 200-day moving average. Year-to-date, it is down almost 5%. Investors are clearly waiting to see whether the waters deal — and its hoped-for $5 billion valuation — actually materialises.

A Quarter That Defied Expectations

Against this backdrop of restructuring, Nestlé’s first-quarter numbers, released on 23 April, provided a genuine surprise. Organic sales growth came in at 3.5%, well ahead of the 2.4% analysts had pencilled in. Coffee, ready meals and snacks were the standout performers.

The reported revenue figure, however, tells a different story. Sales fell 5.7% to 21.3 billion CHF, hammered by a 9.3% negative currency impact. There was also a 90-basis-point drag from the infant formula recall in January 2026. The underlying momentum, though, is clearly improving.

Nestle at a turning point? This analysis reveals what investors need to know now.

Barclays analyst Warren Ackerman, who rates the stock “Equal Weight” with a 86 CHF price target, acknowledges the progress on the restructuring but warns that market expectations are rising. The shares have rallied 7.3% over the past week, recovering sharply from their year low, but remain around 15% below the 52-week high of 94.88 CHF.

Guidance and Dividends: The Steady Hand

Management has held firm on its full-year outlook: organic sales growth of 3% to 4%, accelerating real volume growth, and an improved operating margin — weighted towards the second half. Free cash flow is expected to exceed 9 billion CHF.

At the annual general meeting on 16 April, shareholders approved a dividend of 3.10 CHF per share — the 30th consecutive increase. In a period of deep structural change and mixed market signals, that dividend streak may be the most consistent signal Nestlé is sending right now.

Ad

Nestle Stock: New Analysis - 28 April

Fresh Nestle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nestle analysis...

So schätzen die Börsenprofis Nestlé’s Aktien ein!

<b>So schätzen die Börsenprofis  Nestlé’s Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH0038863350 | NESTLé’S | boerse | 69255232 |